Caliway Biopharmaceuticals Co., Ltd. announced a oversubscribed private placement that it has issued 8,000,000 new shares at a price of $12.5 per share for the gross proceeds of $100 million on December 16, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
380 TWD | +0.26% | 0.00% | +98.69% |
1st Jan change | Capi. | |
---|---|---|
+98.69% | 1.63B | |
+29.46% | 684B | |
+30.34% | 568B | |
-3.96% | 361B | |
+17.59% | 329B | |
+4.25% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.33% | 166B |
- Stock Market
- Equities
- 6919 Stock
- News Caliway Biopharmaceuticals Co., Ltd.
- Caliway Biopharmaceuticals Co., Ltd. announced that it has received $100 million in funding